FCB Health New York announced that it has hired Érico Braga and Fabio Rodrigues for creative posts Monday afternoon.
The IPG Health imprint said Braga will serve as group creative director of craft and arts, while Rodrigues will lead as group creative director.
Braga and Rodrigues will report into FCB Health New York’s chief creative officer Kathleen Nanda.
“We are thrilled to welcome Érico and Fabio to the agency. They each bring a rich and unique perspective to the work, and I’m confident their contributions to our clients’ business and teams will be invaluable,” Nanda said in a statement. “As the leading healthcare communications agency, we are relentless about raising the bar for creativity and redefining it. And as healthcare, technology and data continue to evolve, so too must creativity, and we owe it to our clients to constantly be one step ahead and continuously advancing.”
Braga brings more than 20 years of industry experience to FCB Health New York, having most recently served as executive creative director at Africa DDB São Paulo in Brazil. At the agency, Braga is responsible for leading its Craft Bar offering that supports art direction and craft with FCB Health New York.
Meanwhile, Rodrigues joins from his most recent role as executive creative director at VMLY&R Health. Rodrigues is also a boomerang, having previously worked at IPG Health in its McCann Health New York outfit as well as at Area 23. Through his lengthy advertising career, Rodrigues has assisted several blue chip names in pharma, including GSK as well as Johnson & Johnson.
Both leaders have been honored at industry award ceremonies, including the Cannes Lions and The One Show.
The two hirings point to the latest growth efforts taking place at FCB Health New York.
According to MM+M’s 2022 Agency 100 rankings, the firm’s revenue grew 6% to an estimated $370 million in 2021, up from $350 million in 2020, while staff count rose from 1,070 to 1,320.
During the year, the agency notched 27 new business wins, including the likes of Pfizer, Novartis, Sanofi and Alexion Pharmaceuticals, among others.